Generali, D., Buffa, F., Berruti, A., Brizzi, M., Campo, L., Bonardi, S., . . . Fox, S. (2009). Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Generali, D., et al. Phosphorylated ERalpha, HIF-1alpha, and MAPK Signaling as Predictors of Primary Endocrine Treatment Response and Resistance in Patients with Breast Cancer. 2009.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Generali, D., et al. Phosphorylated ERalpha, HIF-1alpha, and MAPK Signaling as Predictors of Primary Endocrine Treatment Response and Resistance in Patients with Breast Cancer. 2009.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.